Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Hanscom

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Substance Use|February 6, 2023
Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: results from HPTN 074Tran Viet Ha, Irving F Hoffman, William C Miller, et al.
The New England Journal of Medicine|February 22, 2008
Surgical versus nonsurgical therapy for lumbar spinal stenosisJames N Weinstein, Tor D Tosteson, Jon D Lurie, et al.
Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.
AIDS and Behavior|January 3, 2019
Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject DrugsJessica M Fogel, Yinfeng Zhang, Philip J Palumbo, et al.
Journal of the International AIDS Society|July 13, 2023
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysisSarah E Stansfield, Jesse Heitner, Kate M Mitchell, et al.
BMC Infectious Diseases|May 11, 2023
Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trialKostyantyn Dumchev, Xu Guo, Tran Viet Ha, et al.
Journal of the International AIDS Society|July 2, 2025
Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysisSarah E Stansfield, Mia Moore, Lise Jamieson, et al.
The Journal of Infectious Diseases|November 8, 2022
Multiple Infection and Human Immunodeficiency Virus Superinfection Among Persons who Inject Drugs in Indonesia and UkrainePhilip J Palumbo, Wendy Grant-McAuley, Mary Kate Grabowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083Meredith E Clement, Brett Hanscom, Daniel Haines, et al.
The Lancet. HIV|March 15, 2025
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trialLynda Stranix-Chibanda, Erica L Hamilton, Julie Ngo, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Substance Use|February 6, 2023
Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: results from HPTN 074Tran Viet Ha, Irving F Hoffman, William C Miller, et al.
The New England Journal of Medicine|February 22, 2008
Surgical versus nonsurgical therapy for lumbar spinal stenosisJames N Weinstein, Tor D Tosteson, Jon D Lurie, et al.
Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.
AIDS and Behavior|January 3, 2019
Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject DrugsJessica M Fogel, Yinfeng Zhang, Philip J Palumbo, et al.
Journal of the International AIDS Society|July 13, 2023
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysisSarah E Stansfield, Jesse Heitner, Kate M Mitchell, et al.
BMC Infectious Diseases|May 11, 2023
Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trialKostyantyn Dumchev, Xu Guo, Tran Viet Ha, et al.
Journal of the International AIDS Society|July 2, 2025
Estimated impact of long-acting injectable PrEP in South Africa: a model comparison analysisSarah E Stansfield, Mia Moore, Lise Jamieson, et al.
The Journal of Infectious Diseases|November 8, 2022
Multiple Infection and Human Immunodeficiency Virus Superinfection Among Persons who Inject Drugs in Indonesia and UkrainePhilip J Palumbo, Wendy Grant-McAuley, Mary Kate Grabowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083Meredith E Clement, Brett Hanscom, Daniel Haines, et al.
The Lancet. HIV|March 15, 2025
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trialLynda Stranix-Chibanda, Erica L Hamilton, Julie Ngo, et al.
Pageof 8